AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Tiziana Life Sciences announced that its senior leadership team will present at the Jefferies London Healthcare Conference. CEO Ivor Elrifi and CFO Keeren Shah will deliver a corporate overview highlighting the company's innovative pipeline and recent clinical milestones. The presentation will include an update on lead candidate foralumab, a fully human anti-CD3 monoclonal antibody in clinical development for neurodegenerative diseases.
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet